COMMUNIQUÉS West-GlobeNewswire

Sorrento Therapeutics CEO Dr. Ji to Present at Roth Capital Partners 30th Annual Growth Stock Conference on 03/12/18
09/03/2018
SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today that it will present at Roth Capital Partners 30 th annual growth stock conference on 03/12/18 at 1 [...]
Xeris Pharmaceuticals, Inc. Completes $55 million In New Financing To Support Ready-To-Use Glucagon Development
09/03/2018
CHICAGO, IL, March 08, 2018 (GLOBE NEWSWIRE) -- CHICAGO, IL; March 8, 2018 (GLOBE NEWSWIRE) – Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to [...]
Alphatec Spine Disrupts Market with Acquisition of SafeOp Surgical, ~$50M Equity Financing, and Strategic Leadership Appointments
08/03/2018
Acquisition provides Alphatec most advanced automated neuromonitoring technology Private placement funded by senior leadership, new and existing investors Luiz Pimenta, MD, PhD, to assume role of Chief Medical Officer [...]
Alphatec Spine Reports Fourth Quarter and Full Year 2017 Financial Results
08/03/2018
CARLSBAD, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq: ATEC ), a provider of innovative spine surgery solutions with a mission to improve patient lives [...]
Immunovaccine Chief Medical Officer Dr. Gabriela Rosu to Present at the Oncology Meeting Innovations (OMI) Annual Summit on Hematologic Malignancies
08/03/2018
HALIFAX, Nova Scotia, March 08, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that its Chief Medical Officer, Gabriela Nicola Rosu, MD [...]
Clearside Biomedical to Report Fourth Quarter and Full Year 2017 Financial Results on March 14, 2018 – Conference Call to Follow
08/03/2018
ALPHARETTA, Ga., March 08, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases [...]
Cara Therapeutics to Announce Fourth Quarter and Full Year 2017 Financial Results on March 15, 2018
08/03/2018
STAMFORD, Conn., March 08, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA ), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]
Cytori Reports Fourth Quarter and Full Year 2017 Business and Financial Results
08/03/2018
SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX ) (“Cytori” or the “Company”) today announced its fourth quarter and year-end 2017 financial results and provided updates on its corporate [...]
Otonomy Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
08/03/2018
Type C meeting completed with FDA for OTIVIDEX™ in Ménière’s disease Consistent with prior guidance, pivotal trial for OTIVIDEX to start mid-2018 Conference call and webcast today at 4:30 p.m. EST SAN DIEGO, March 08, [...]
The Cooper Companies Announces First Quarter 2018 Results
08/03/2018
PLEASANTON, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced financial results for the fiscal first quarter ended January 31, 2018. First quarter revenue increased 18% [...]
OncoMed Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights
08/03/2018
Navicixizumab and anti-TIGIT data expected in the 2 nd Half of 2018 Management to Host Conference Call/Webcast this afternoon at 4:30 p.m. ET / 1:30 p.m. PT REDWOOD CITY, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- [...]
Alpha Pro Tech, LTD. Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2017
08/03/2018
Net income for 2017 was $2.6 million, or $0.18 per diluted share, compared to $3.2 million, or $0.19 per diluted share, for 2016 Excluding a $619,000 accrual related to the death of our former President and Chairman, [...]
Albert White to Succeed Robert Weiss as CEO of the Cooper Companies
08/03/2018
PLEASANTON, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced that its Board of Directors has named Albert G. White III President and Chief Executive Officer of The [...]
INSYS Therapeutics Reports Fourth Quarter and Full Year 2017 Results
08/03/2018
PHOENIX, March 08, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today reported [...]
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results
08/03/2018
- On track to begin first company-sponsored clinical trials of a CRISPR-based therapy - - Wholly-owned CRISPR-based allogeneic CAR-T programs advancing rapidly - ZUG, Switzerland and CAMBRIDGE, Mass., March 08, 2018 ( [...]
Clearside Biomedical to Present at the Cowen and Company 38th Annual Health Care Conference
08/03/2018
ALPHARETTA, Ga., March 08, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases [...]
Calithera Biosciences Reports Fourth Quarter 2017 Financial Results and Recent Highlights
08/03/2018
SOUTH SAN FRANCISCO, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA ), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs [...]
The Joint Corp. Reports Fourth Quarter and Full Year 2017 Financial Results
08/03/2018
29% Annual System-Wide Gross Sales Increase to $126.9 Million for 2017 23% Annual Revenue Growth to $25.2 Million for 2017 $11.9 Million Improvement in Net Loss to $(3.3) Million for 2017 $7.6 Million, or 99%, [...]
Codexis Reports 2017 Fourth Quarter and Full Year Financial Results
08/03/2018
2017 revenues of $50 million include a 74% increase in product sales Introduces 2018 financial guidance Conference call begins at 4:30 pm Eastern time today Accompanying slide presentation available on Investor section [...]

Pages